What happens when the Isis&Genzyme&Sanofi competing drug is approved Jan 29th?
A panel already voted in favor of approval.
Sanofi has more marketing clout than this rinky dink operation.
They will eat their lunch.
You'll have to cut the Company's overly optimistic projections in half?
If this were a $3 stock, I'd have reservations about buying shares.